SPONSORED – Neuropathy is becoming a bigger problem for more people than ever before. If you`re suffering from stabbing pain, ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

There's a potential new treatment for people who develop shingles that spread to the eye. Doctors say about 8% of shingles ...

Dr. White says these devices have been successfully treating patients in pain for 50 years, but they just keep getting better ...

What are the uses of camphor? Camphor offers relief for pain, inflammation, congestion, and skin issues but should be used ...

The CHMP recommends approval for AZN's Wainzua for treating polyneuropathy associated with hereditary transthyretin-mediated ...

According to the company, its data replicate and expand upon the potential of ER-100 to improve retinal ganglion cell ...

AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with ...

A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely ...

AstraZeneca and Ionis are collaborating on the commercialisation of the drug following a December 2021 global agreement.

Diabetics should clear out plenty of room in their medicine cabinets for their new gear, including (from left) disposable ...

Foresee Pharmaceuticals Announces Preliminary Results from a Phase 1 Clinical Trial, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of Linvemastat (FP-020), a Novel and ...